• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 8
  3. Author

Online ISSN: 2515-8260

Volume7, Issue8

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF PROCESS RELATED IMPURITY FROM NIFEDIPINE

    Dr.Manisha. S. Kedar, Dr.Manoj. P. Shirbhate, Manjusha. S. Sanap, Dr.Rani. S. Kankate, Prerana. B. Jadhav, Bhagyashri. J. Warude

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 8, Pages 5593-5601

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

- The process related impurity of Nifedipine diethyl 1, 4-dihydro-2, 6-dimethyl pyridine 3, 5 dicarboxylate in bulk and formulations was synthesized. The characterization of synthesized impurities by using FTIR, NMR and MS. The RP-HPLC method was developed according to ICH Q2B guidelines for quantitation of impurity in bulk and formulations. The method was validated as per ICH guidelines. The method was found to be linear, precise, accurate, robust and rugged. The diethyl 1,4-dihydro-2,6-dimethyl pyridine 3,5 dicarboxylate impurity was quantified from bulk Nifedipine  and its marketed tablet formulations. It was revealed that the amount of impurity present in tablet batch I and II was found to be 0.26% and 0.32% respectively and the bulk was found to be negligible.
Keywords:
  • PDF (392 K)
  • XML
(2021). DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF PROCESS RELATED IMPURITY FROM NIFEDIPINE. European Journal of Molecular & Clinical Medicine, 7(8), 5593-5601.
Dr.Manisha. S. Kedar, Dr.Manoj. P. Shirbhate, Manjusha. S. Sanap, Dr.Rani. S. Kankate, Prerana. B. Jadhav, Bhagyashri. J. Warude. "DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF PROCESS RELATED IMPURITY FROM NIFEDIPINE". European Journal of Molecular & Clinical Medicine, 7, 8, 2021, 5593-5601.
(2021). 'DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF PROCESS RELATED IMPURITY FROM NIFEDIPINE', European Journal of Molecular & Clinical Medicine, 7(8), pp. 5593-5601.
DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF PROCESS RELATED IMPURITY FROM NIFEDIPINE. European Journal of Molecular & Clinical Medicine, 2021; 7(8): 5593-5601.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 30
  • PDF Download: 37
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  info@ejmcm.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

Editorial Team:  editor@ejmcm.com

For Special Issue Proposal : chiefeditor.ejmcm@gmail.com / info@ejmcm.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus